Songyot Pilasant1, Wantanee Kulpeng1, Pitsaphun Werayingyong1*, Nattha Tritasavit1, Inthira Yamabhai1, Yot Teerawattananon1, Sangay Wangmo2 and Sripen Tantivess1 Abstract Background: The Maternal and Child Health Voucher Scheme (MCHVS) was introduced in Myanmar to address the high rate of mat

About the study Objective: This study aimed to quantify heterogeneity in the value for money of precision medicine (PM) by application types across contexts and conditions and to quantify sources of heterogeneity to areas of particular promises or concerns as the field of PM moves forward. Methods

Over the years, Kenya has emerged as an economic powerhouse in the African continent. In unveiling his ‘Big Four’ strategy, the President of Kenya has made universal health coverage (UHC) a priority agenda for the policymakers as the country seeks to align economic growth with sustainable developmen

May 8 – 10, 2024 – the Ministry of Public Health, by the Health Intervention Technology Assessment Thailand (HITAP), partnered with the International Society for Priorities in Health (ISPH), a network of researchers, medical professionals, and policy-makers working in health prioritization, to organ

On 14August 2018, Dr. Mayfong Mayxay, Vice-Dean of the Research department at the Faculty of Postgraduate Studies in Laos University of Health Science, visited the Health Intervention and Technology Assessment Program (HITAP) to learn about Health Technology Assessment (HTA) and to discuss potential

The Association of Southeast Asian Nations (ASEAN) region is characterised by diversity. Progress towards Universal Health Coverage (UHC) and institutionalisation of priority setting through Health Technology Assessment (HTA) is varied and is dependent on several country-specific factors such as the proportion of public investment in health, politi

This article is part 1 of the blog series: “Knowledge Translation: The Key to Turning Mathematical Models from a Black Box into a Powerful Tool for Policy Decision-Making” As health systems become more complex, decision-makers need tools that can help them evaluate long-term outcomes and choose

During this period of rapid change and transition with the COVID-19 pandemic, the use of evidence is increasingly important. A webinar series and corresponding toolkit can support country partners and researchers to continue growing in knowledge and understanding in this field despite the restrictions on travel and face-to-face support. The webinar

Philadelphia (CNN) — Beth Rutstein rolls up the sleeves of her T-shirt, juggles a stack of fliers and knocks on the door of a stranger’s home. She’s on a mission to save lives.After wiping sweat from her face beneath the sweltering afternoon sun on a recent Thursday, she ascends another set of stair

Kidney failure (KF)[1] is a life-threatening disease that requires either kidney transplantation or dialysis for survival (1, 2). As of 2019, it was estimated that globally, 1.4 million deaths occurred on account of chronic kidney disease (CKD) (3). The cost of treatment for KF is also high, leading to catastrophic household expenditure to househo